rs113100797
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1
The ENST00000252826.10(TRPM4):βc.2283_2294delβ(p.Cys763_Arg766del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.00711 in 1,556,054 control chromosomes in the GnomAD database, including 669 homozygotes. Variant has been reported in ClinVar as Likely benign (β β ). Synonymous variant affecting the same amino acid position (i.e. C758C) has been classified as Likely benign.
Frequency
Genomes: π 0.037 ( 339 hom., cov: 31)
Exomes π: 0.0038 ( 330 hom. )
Consequence
TRPM4
ENST00000252826.10 inframe_deletion
ENST00000252826.10 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.36
Genes affected
TRPM4 (HGNC:17993): (transient receptor potential cation channel subfamily M member 4) The protein encoded by this gene is a calcium-activated nonselective ion channel that mediates transport of monovalent cations across membranes, thereby depolarizing the membrane. The activity of the encoded protein increases with increasing intracellular calcium concentration, but this channel does not transport calcium. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in ENST00000252826.10.
BP6
Variant 19-49196501-TGCTGCGGGGGCC-T is Benign according to our data. Variant chr19-49196501-TGCTGCGGGGGCC-T is described in ClinVar as [Likely_benign]. Clinvar id is 415729.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-49196501-TGCTGCGGGGGCC-T is described in Lovd as [Benign]. Variant chr19-49196501-TGCTGCGGGGGCC-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPM4 | NM_017636.4 | c.2283_2294del | p.Cys763_Arg766del | inframe_deletion | 17/25 | ENST00000252826.10 | NP_060106.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPM4 | ENST00000252826.10 | c.2283_2294del | p.Cys763_Arg766del | inframe_deletion | 17/25 | 1 | NM_017636.4 | ENSP00000252826 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0369 AC: 5611AN: 152062Hom.: 327 Cov.: 31
GnomAD3 genomes
AF:
AC:
5611
AN:
152062
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00859 AC: 1356AN: 157942Hom.: 76 AF XY: 0.00673 AC XY: 577AN XY: 85712
GnomAD3 exomes
AF:
AC:
1356
AN:
157942
Hom.:
AF XY:
AC XY:
577
AN XY:
85712
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00384 AC: 5392AN: 1403874Hom.: 330 AF XY: 0.00325 AC XY: 2258AN XY: 693886
GnomAD4 exome
AF:
AC:
5392
AN:
1403874
Hom.:
AF XY:
AC XY:
2258
AN XY:
693886
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0372 AC: 5664AN: 152180Hom.: 339 Cov.: 31 AF XY: 0.0365 AC XY: 2716AN XY: 74414
GnomAD4 genome
AF:
AC:
5664
AN:
152180
Hom.:
Cov.:
31
AF XY:
AC XY:
2716
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | May 18, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 17, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 25, 2016 | - - |
Progressive familial heart block type IB Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2016 | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance - |
Restrictive cardiomyopathy;C0878544:Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego | Jan 22, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at